Abstract
Inflammatory carcinoma is a rare and aggressive form of primary epithelial cancer that includes 1–6 % of breast cancer and is associated to a poor prognosis given the high probability of micrometastases at diagnosis; about 20 % of patients have distant metastases at diagnosis [1], with a high incidence of recurrence, higher than those noninflammatory carcinoma.
Inflammatory breast cancer is diagnosed clinically by the rapid appearance of erythema and edema called “orange peel” involving at least one third of the skin around the breast. In this chapter, it discusses the various methods of imaging and its usefulness in the diagnosis of inflammatory breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yang WT, Le-Petross HT, Macapinlac H, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008;109:417–26.
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Bonnier P, Charpin C, et al. Inflammatory carcinomas of the breast a clinical, pathological, or a clinical and pathological definition? Int J Cancer. 1995;62:382–5.
Le-Petross H, Uppendahl L, Stafford J. Sonographic features of inflammatory breast cancer. Semin Roentgenol. 2011;46(4):275–9.
Haagensen C. Diseases of the breast. 2ath ed. Philadelphia: Pasauder; 1971. p. 569–84.
Kim T, Lau J, Erban J. Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer. 2006;7:386–95. CrossRefMedlineWeb of Science.
Kushwaha AC, Whitman GJ, Stelling CB, Cristofanilli MC, Buzdar AU. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000;174:535–8.
Tardivon AA, Viala J, Rudelli AC, Guinebretiere JM, Vanel D. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol. 1997;24:124–30.
Buzdar AU, et al. Effectiveness of mastectomy. Cancer. 1995;76:2286–2290.
Yang WT. Advances in imaging of inflammatory breast cancer. Cancer. 2010;116:2755–7.
Lee KW, Chung SY, Yang I, et al. Inflammatory breast cancer imaging findings. J Clin Imaging. 2005;29:22–5.
Günhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829–38.
Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75.
American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). 3rd ed. Reston: American College of Radiology; 1998. p. 121–39.
Huong T, Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S. MRI features of inflammatory breast cancer. AJR Am J Roentgenol. 2011;197(4):769–76.
Sirishma Kalli S, Freer PE, Elizabeth A, Rafferty EA. 16 Lesions of the skin and superficial tissue at breast MR imaging. Radiographics. 2010;30:1891–913.
Renz DM, Baltzer PAT, Böttcher J, Thaher F, Gajda M, Camara O, Runnebaum IB, Kaiser WA. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol. 2008;18:2370–80.
Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S. MRI features of inflammatory breast cancer. AJR. 2011;197(4):769–76.
Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB. Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab- initial experience 1. Radiology. 2007;244(3):727–35.
Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat. 2004;83:67–76.
Muna M, Siema B, Bakheet M, et al. 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg. Société Internationale de Chirurgie. 2003;27(10):1099–104.
Robertson FM, Bondy M, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75.
Alberini J-L, Lerebours L, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009;115:5038–47.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Villaseñor-Navarro, Y. et al. (2013). Imaging in Inflammatory Carcinoma. In: de la Garza-Salazar, J., Meneses-Garcia, A., Arce-Salinas, C. (eds) Inflammatory Breast Cancer. Springer, London. https://doi.org/10.1007/978-0-85729-991-8_5
Download citation
DOI: https://doi.org/10.1007/978-0-85729-991-8_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-990-1
Online ISBN: 978-0-85729-991-8
eBook Packages: MedicineMedicine (R0)